SmofKabiven Electrolyte Free Emulsion for Infusion

**4.3 Contraindications** - Hypersensitivity to fish-, egg-, soya- or peanut protein or to any of the active substances or excipients listed in section 6.1 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_ - Severe hyperlipidemia - Severe liver insufficiency - Severe blood coagulation disorders - Congenital errors of amino acid metabolism - Severe renal insufficiency without access to hemofiltration or dialysis - Acute shock - Uncontrolled hyperglycaemia - General contraindications to infusion therapy: acute pulmonary oedema, hyperhydration, and decompensated cardiac insufficiency - Hemophagocytotic syndrome - Unstable conditions (e.g. severe post-traumatic conditions, uncompensated diabetes mellitus, acute myocardial infarction, stroke, embolism, metabolic acidosis, severe sepsis, hypotonic dehydration and hyperosmolar coma) - Infants and children under 2 years of age

Indication Information

**4.1 Therapeutic indications** Parenteral nutrition for adults and children aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.

Basic Information

Regulatory Information

Company Information

Active Ingredients

Detailed Information

Contraindications

Indication Information